Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Central Nervous System Bleeding in Pediatric Patients With Factor Xiii Deficiency: A Study on 23 New Cases Publisher Pubmed



Naderi M1 ; Alizadeh S2 ; Kazemi A3 ; Tabibian S2 ; Zaker F4 ; Bamedi T1 ; Kashani Khatib Z5 ; Dorgalaleh A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical sciences, Zahedan, Iran
  2. 2. Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Hematology, Allied Medical School, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Hematology, Cellular and Molecular Research Center, School of Allied Medical Sciences, Iran University of Medical Sciences
  5. 5. Department of Hematology, Tarbiat Modares University, Tehran, Iran

Source: Hematology Published:2015


Abstract

Background: Factor XIII (FXIII) deficiency is an extremely rare bleeding disorder, which has the highest incidence in Sistan and Baluchistan Province in Iran, compared to its overall incidence around the world. This disorder has different clinical manifestations ranging from mild bleeding tendency to lethal bleeding episodes including central nervous system (CNS) hemorrhage. The aim of this study was to evaluate the demographic data, pattern of CNS bleeding, and the role of plasminogen activator inhibitor-1 (PAI-1) (PAI-1) 4G/5G and thrombin activatable fibrinolysis inhibitor (TAFI) Thr325Ile polymorphisms in intracranial and extracranial hemorrhages in 23 new cases of FXIII-deficient subjects. Methods: This case–control study was conducted on 23 FXIII-deficient patients with CNS bleeding episodes and 23 patients as the control group with FXIII deficiency but without any history of CNS bleeding. Initially, to confirm the molecular defect, both groups were evaluated for the most frequently reported mutation of FXIII (Trp187Arg mutation) in a previous study in Sistan and Baluchistan Province. Then, demographic data, clinical manifestations, and pattern of CNS bleeding were determined. Eventually, the patients were assessed for PAI-14G/5G and TAFI Thr325Ile polymorphisms. Results: The results of this study revealed that all the subjects (including the case and control groups) were homozygous for Trp187Arg mutation. Nineteen patients (82.6%) had intracranial hemorrhage (ICH) and four patients (17.4%) had extracranial hemorrhage (ECH). Intraparenchymal hemorrhage was the most common form of ICH (89.5%), and epidural hemorrhage was observed in two patients (10.5%). Anatomic regions in patients with intraparenchymal hemorrhage were temporal in six (35.3%), occipital in four (23.5%), diffused intraparenchymal in four (23.5%), temporal-occipital in two (11.8%), and subdural with temporal in one (5.9%) patient. We found that in the case group, 14 patients (60.8%) were homozygous for TAFI Thr325Ile polymorphism and 8 cases (34.7%) were heterozygous. In the control group, 4 (17.4%) and 13 (56.5%) patients were homozygous and heterozygous, respectively (P < 0.001 vs. P < 0.01).We also found that an equal number of patients (two individuals) in the case and control groups (8.7% in each group) were heterozygous for PAI-14G/5G polymorphism. Conclusion: It seems that PAI-14G/5G polymorphism does not have any effect on occurrence of ICH and ECH in patients with FXIII deficiency, while TAFI Thr325Ile is a strong genetic risk factor (odds ratio:14.9, 95% confidence interval: 7.4–31.1). © W. S. Maney & Son Ltd 2015.
Related Docs
View other Related Docs
1. Factor Xiii Deficiency in Iran: A Comprehensive Review of the Literature, Seminars in Thrombosis and Hemostasis (2015)
2. Association Between Expression of Mmp-2 and Mmp-9 Genes and Pathogenesis of Intracranial Hemorrhage in Severe Coagulation Factor Xiii Deficiency, Hematology (United Kingdom) (2015)
3. Coagulation Factor Xiii-A A614t Gene Variation Is Suggestive of Founder Effect in Iranian Patients With Sever Congenital Factor Xiii Deficiency, Journal of Cellular and Molecular Anesthesia (2016)
4. First Cases of Severe Congenital Factor Xiii Deficiency in Southwestern Afghanistan in the Vicinity of Southeast of Iran, Blood Coagulation and Fibrinolysis (2015)
5. Relationship Between the Matrix Metalloproteinases and the Occurrence of Central Nervous System Bleeding in Factor Xiii Deficiency, Journal of Isfahan Medical School (2015)
6. Establishment of a Prenatal Diagnosis Schedule As Part of a Prophylaxis Program of Factor Xiii Deficiency in the Southeast of Iran, Blood Coagulation and Fibrinolysis (2016)
7. Risk and Management of Intracerebral Hemorrhage in Patients With Bleeding Disorders, Seminars in Thrombosis and Hemostasis (2022)
8. Effect of Social Factors on the Highest Global Incidence of Congenital Factor Xiii Deficiency in Southeast of Iran, Archives of Iranian Medicine (2015)
Experts (# of related papers)
View all Related Experts
Shaban Alizadeh (7)
Zahra Kashanikhatib (1)
Other Related Docs
9. Diagnosis of Factor Xiii Deficiency, Hematology (2016)